- Home
- LSTA vs CING Comparison
LSTA vs CING Comparison
Compare LSTA & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- CING
- Stock Information
- Founded
- LSTA 1980
- CING 2012
- Country
- LSTA United States
- CING United States
- Employees
- LSTA N/A
- CING N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- CING Health Care
- Exchange
- LSTA Nasdaq
- CING Nasdaq
- Market Cap
- LSTA 25.1M
- CING 26.7M
- IPO Year
- LSTA N/A
- CING 2021
- Fundamental
- Price
- LSTA $2.53
- CING $4.04
- Analyst Decision
- LSTA Strong Buy
- CING Strong Buy
- Analyst Count
- LSTA 2
- CING 4
- Target Price
- LSTA $23.50
- CING $30.67
- AVG Volume (30 Days)
- LSTA 33.8K
- CING 173.5K
- Earning Date
- LSTA 08-07-2025
- CING 08-26-2025
- Dividend Yield
- LSTA N/A
- CING N/A
- EPS Growth
- LSTA N/A
- CING N/A
- EPS
- LSTA N/A
- CING N/A
- Revenue
- LSTA $1,070,000.00
- CING N/A
- Revenue This Year
- LSTA N/A
- CING N/A
- Revenue Next Year
- LSTA N/A
- CING N/A
- P/E Ratio
- LSTA N/A
- CING N/A
- Revenue Growth
- LSTA N/A
- CING N/A
- 52 Week Low
- LSTA $1.87
- CING $3.02
- 52 Week High
- LSTA $4.20
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- LSTA 45.71
- CING 40.42
- Support Level
- LSTA $2.55
- CING $3.50
- Resistance Level
- LSTA $2.87
- CING $4.31
- Average True Range (ATR)
- LSTA 0.20
- CING 0.46
- MACD
- LSTA -0.02
- CING -0.15
- Stochastic Oscillator
- LSTA 12.70
- CING 24.11
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.